Home
 /
Papers
 /
Synthetic Biology
 /
Generative design of novel bacteriophages with genome language models
Preprint
Open access
V1
Top 1% · Validated by QED

Generative design of novel bacteriophages with genome language models

Samuel H. King, Claudia L. Driscoll, David B. Li +5 more
September 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.09.12.675911
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Synthetic Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

This work establishes, for the first time, that AI can design living organisms at genome scale—generating viable bacteriophages that outcompete wild-type and overcome bacterial resistance, opening an entirely new frontier in synthetic biology.

QED claims analysis

Summary

Genome language models Evo 1 and Evo 2 can generate complete, viable bacteriophage genomes with substantial evolutionary novelty that exhibit superior fitness compared to natural templates and form diverse cocktails capable of rapidly overcoming bacterial resistance that the natural phage cannot defeat, establishing generative AI as a viable approach for whole-genome design with therapeutic applications.

See full analysis
Main Claim 1 –

Pretrained Evo Models Generate Realistic, Highly Novel Phage Genomes

Supporting evidence

  • Microviridae Fine-Tuning Enables Diverse, Controlled ΦX174-Like Genome Generation
Main Claim 2 –

Genome Language Models Design Viable Phages with Controlled Tropism

Supporting evidence

  • Viable Generated Phages Show Novel Genome Architectures and Protein Structures
Main Claim 3 –

AI-Generated Phages Outcompete ΦX174 and Lyse Hosts Faster

Main Claim 4 –

Generated Phage Cocktail Rapidly Overcomes ΦX174-Resistant E. coli

Abstract

Many important biological functions arise not from single genes, but from complex interactions encoded by entire genomes. Genome language models have emerged as a promising strategy for designing biological systems, but their ability to generate functional sequences at the scale of whole genomes has remained untested. Here, we report the first generative design of viable bacteriophage genomes. We leveraged frontier genome language models, Evo 1 and Evo 2, to generate whole-genome sequences with realistic genetic architectures and desirable host tropism, using the lytic phage ΦX174 as our design template. Experimental testing of AI-generated genomes yielded 16 viable phages with substantial evolutionary novelty. Cryo-electron microscopy revealed that one of the generated phages utilizes an evolutionarily distant DNA packaging protein within its capsid. Multiple phages demonstrate higher fitness than ΦX174 in growth competitions and in their lysis kinetics. A cocktail of the generated phages rapidly overcomes ΦX174-resistance in three E. coli strains, demonstrating the potential utility of our approach for designing phage therapies against rapidly evolving bacterial pathogens. This work provides a blueprint for the design of diverse synthetic bacteriophages and, more broadly, lays a foundation for the generative design of useful living systems at the genome scale.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?